BMW just embarked on the ambitious goal of making the world’s fastest racing drones, inking a development deal with the Drone Racing League.
According to the league’s CEO, the partnership will boost the German automaker’s reach among millennials.
“We’re attracting a young, excited audience that’s interested in things like technology, video games, drones,” Nicholas Horbaczewski told Cheddar. “So [for brands like BMW] it’s a way to reach those consumers. In the past two years we’ve had over 55 million TV viewers.”
And the DRL is not just about the excitement of the sport, it’s also about the technology. Last year members hand-built a drone with a speed of 162 miles per hour, a record it hopes to break with the help of BMW.
“All the technology that’s used in the league is developed by DRL,” Horbaczewski said. “We design the drones in-house, we design the radio communication equipment in-house … It’s truly a technology innovation company.”
The BMW deal wouldn’t be DRL’s first, though. The league has also partnered with companies such as Swatch, Cox Communications, and insurance firm Allianz.
For the full interview, [click here](https://cheddar.com/videos/the-drone-racing-league-teams-up-with-bmw).
Joby CPO Eric Allison discusses the UAE’s historic EVTOL take off, marking Dubai as the launchpad for global air taxi adoption and Joby’s commercial readiness.
CFRA’s Angelo Zino joins us to unpack Meta’s Superintelligence Labs and what it means for the future of AI, innovation, and the company’s bold new direction.
AIRO CEO Joe Burns and Executive Chairman Chirinjeev Kathuria talks the future of aerospace, drones, and urban air mobility through innovation and synergy.
NYC's mayoral race heats up with a socialist candidate aiming to make the city affordable—and rattling the financial sector. Plus: Coinbase's prospects.
Mark Hamrick of Bankrate discusses the jobs market, AI's growing impact on employment, and how markets are reacting to today’s surprising payroll data.
Amanda Chu of POLITICO reveals how lawmakers are betting millions on pharma stocks even as Trump threatens tariffs and demands steep drug price cuts. Watch!
